The image of the wise and skilful healer has driven countless clinicians to dedicate their lives to the profession, but that ...

A multinational study has suggested a new potential side effect of GLP-1RA use: nail detachment. Presented at the at European Academy of Dermatology and Venereology 2026 Congress this month, the ...

The investigational weight-loss drug retatrutide cut sleep apnoea events by 25 to 34 an hour at its two highest doses, versus about 10 with placebo, in two industry-funded phase 3 trials. The ...

There may be more than one way to successfully come off long-term proton pump inhibitors, with a trial comparing three deprescribing strategies finding almost half of patients substantially stopped ...

Suspected paper mill papers in leading cancer journals are racking up far more citations than genuine articles, despite attracting fewer readers, according to an Australian-led forensic bibliometric ...

Repurposed cancer drugs and investigational disease-specific agents are shifting the treatment paradigm for hereditary haemorrhagic telangiectasia, an inherited bleeding disorder with potentially ...

Survivors of childhood abuse have a graded increase in risk of chronic constipation and irritable bowel syndrome with constipation (IBS-C) later in life, data from the Nurses Health Study has shown. A ...

These videos were created independently by the limbic. All content was developed by the presenters and views are those of the presenters alone.

The overall risk of thrombosis is similar with administration of Factor VIII or IX replacement products, but is higher with other bleeding disorder treatments, a new analysis of 15 years’ surveillance ...

An underappreciation of menstruation and pregnancy in iron loss, and an overemphasis on nutrition and iron replacement as treatment, are impeding progress for women with iron deficiency, Blood 2026 ...

HSANZ wants to establish itself as the “authoritative peak body” for haematology in Australia and New Zealand over the next five years, with plans to expand its education offerings, create an advocacy ...

GLP-1/GIP RAs are associated with a modest and borderline reduction in the risk of progression to advanced kidney disease compared with finerenone in people with type 2 diabetes and moderate kidney ...